Pulmonary Artery Pressure Trajectories in Heart Failure Patients Treated with GLP-1 Receptor Agonists
GLP1-RA use in HF patients was significantly associated with reductions in body weight and PAPs at 6 months, despite no changes in GDMT and loop diuretic doses.
Authors
- Oksana Kamneva
- Todd McVeigh
- Erika Nicolsen
- Marat Fudim (ORCID: https://orcid.org/0000-0002-8671-7007)
- Veraprapas Kittipibul (ORCID: https://orcid.org/0000-0002-9107-1837)
- Phuuwadith Wattanachayakul (ORCID: https://orcid.org/0000-0003-0086-5269)
- Haoran Jiang (ORCID: https://orcid.org/0009-0006-9575-3575)
Institutions
- Thomas Jefferson University (US)
- Clinical Research Institute (US)
- Duke Medical Center (US)
- Jefferson Hospital (US)
- Duke University Hospital (US)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1002/ehf2.15308
- Citations
- 3
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.16